Keyphrases
Activated Macrophages
100%
Adherens Junction
100%
C-Src
28%
Catenin
85%
Cell Membrane
14%
Conditioned Medium
14%
Epidermal Growth Factor Receptor
28%
Epithelial Cadherin
71%
Epithelial-mesenchymal Transition
28%
Gefitinib
14%
Hepatoma Cells
100%
HepG2 Cells
57%
Invasive Activity
14%
Invasive Properties
100%
Macrophage Activation
100%
Media Treatment
28%
Migration Behavior
14%
Migration Invasion
14%
Migratory Behavior
14%
Peritoneal Macrophages
14%
RAW Macrophages
14%
Signaling Cascades
14%
Src Kinase Inhibitor
14%
Staining Pattern
14%
THP-1 Cells
14%
Tumor
28%
Tumor Progression
14%
Tumor-associated Macrophages
14%
Tyrosine Phosphorylation
14%
Immunology and Microbiology
Adherens Junction
100%
Cadherin
55%
Catenin
66%
Cell Membrane
11%
Downregulation
11%
Epidermal Growth Factor
22%
Epithelial Mesenchymal Transition
22%
Hepatoma Cell
100%
Macrophage
100%
Macrophage Activation
100%
Oncogene Src
22%
Protein Phosphorylation
11%
Staining
11%
Tumor-Associated Macrophage
11%
Biochemistry, Genetics and Molecular Biology
Adherens Junction
100%
Cadherin
55%
Catenin
66%
Cell Membrane
11%
Downregulation
11%
Epidermal Growth Factor Receptor
22%
Gefitinib
11%
Kinase
11%
Macrophage
100%
Macrophage Activation
100%
Mesenchymal-Epithelial Transition
22%
Oncogene Src
22%
Phosphotransferase
11%
Staining
11%
Tumor Progression
11%
Tumor-Associated Macrophage
11%
Tyrosine Phosphorylation
11%
Pharmacology, Toxicology and Pharmaceutical Science
4 Amino 7 Tert Butyl 5 (4 chlorophenyl)pyrazolo[3,4 D]pyrimidine
16%
Cadherin
83%
Catenin
100%
Epidermal Growth Factor Receptor
33%
Gefitinib
16%
Liver Cell Carcinoma
100%
Neoplasm
50%
Tumor Growth
16%
Neuroscience
Adherens Junction
100%
Behavior (Neuroscience)
9%
Cadherin
45%
Catenin
54%
Cell Membrane
9%
Epidermal Growth Factor Receptor
18%
Epithelial Mesenchymal Transition
18%
Gefitinib
9%
Kinase
9%
Macrophage
100%
Oncogene Src
18%
Protein Phosphorylation
9%
Staining Technique
9%